Fiboresp Tablet is an anti-fibrotic medicine used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF is an irreversible disease that is marked by a progressive decline in lung function. The tissues in the lungs become swollen and scarred over time, due to which it gets difficult to breathe deeply. The scarring makes it hard for the lungs to work properly.
 
Fiboresp Tablet contains ‘Pirfenidone’, which helps in reducing the scarring and swelling in the lungs by decreasing the release/activity of naturally occurring growth factors in the body, thereby helps you breathe better. Fiboresp Tablet helps in slowing down the progress of idiopathic pulmonary fibrosis. 

In some cases, you may experience certain common side effects such as nausea, tiredness, diarrhoea, indigestion, loss of appetite, headache, and photosensitivity. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
 
Consult your doctor before taking Fiboresp Tablet if you are pregnant or breastfeeding. Fiboresp Tablet may cause tiredness and dizziness, so drive with caution. Avoid consuming alcohol with Fiboresp Tablet as it could lead to increased dizziness. Fiboresp Tablet is not recommended for children below 18 years as safety and effectiveness have not been established. Keep your doctor informed about your health condition and medicines to rule out any side effects.

Fiboresp Tablet is an anti-fibrotic medicine used to treat idiopathic pulmonary fibrosis (IPF) in adults. Fiboresp Tablet can help effectively slow the rate of lung function decline by 50%. Fiboresp Tablet helps reduce the scarring and swelling in the lungs by decreasing the release/activity of naturally occurring growth factors in the body, thereby helps you breathe better. Fiboresp Tablet helps in slowing down the progress of idiopathic pulmonary fibrosis.

Do not take Fiboresp Tablet if you are allergic to any of its components; if you have a severe or end-stage liver impairment or kidney disease requiring dialysis; if you are taking fluvoxamine (anti-depressant). Inform your doctor if you are taking any medicines that might make you photosensitive, if you smoke or have kidney or liver problems. Consult your doctor before taking Fiboresp Tablet if you are pregnant or breastfeeding. Fiboresp Tablet may cause tiredness and dizziness, so drive with caution. Avoid consuming alcohol with Fiboresp Tablet as it could lead to increased dizziness. Fiboresp Tablet is not recommended for children below 18 years as safety and effectiveness have not been established.

• Your doctor may advise liver function tests prior to the start of the treatment.
• Regular blood tests are advised at the start of treatment with Fiboresp Tablet and monthly for every 6 months, and then for every 3 months thereafter to check the liver functioning.